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Abstract 
This study explored primary care providers’ (PCPs) experiences with the practice of pharmaceutical care-based medication therapy 
management (MTM).  Qualitative, semi-structured interviews were conducted with six PCPs who have experiences working with 
MTM pharmacists for at least three years. The first author conducted the interviews that were audio-taped, transcribed, and coded 
independently. The codes were then harmonized via discussion and consensus with the other authors. Data were analyzed for themes 
using the hermeneutic-phenomenological method as proposed by Max van Manen.  Three men and three women were interviewed. 
On average, the interviewees have worked with MTM pharmacists for seven years. The six (6) themes uncovered from the interviews 
included: (1) “MTM is just part of our team approach to the practice of medicine”: MTM as an integral part of PCPs’ practices; (2) 
“Frankly it’s education for the patient but it’s also education for me”: MTM services as a source of education; (3)  “It’s not exactly just 
the pharmacist that passes out the medicines at the pharmacy”: The MTM practitioner is different from the dispensing pharmacist; 
(4) “So, less reactive, cleaning up the mess, and more proactive and catching things before they become so involved”: MTM services 
as preventative health care efforts; (5)“I think that time is the big thing”: MTM pharmacists spend more time with patients;  (6) 
“There’s an access piece, there’s an availability piece, there’s a finance piece”: MTM services are underutilized at the clinics.  In 
conclusion, PCPs value having MTM pharmacists as part of their team in ambulatory clinics. MTM pharmacists are considered an 
important source of education to patients as well as to providers as they are seen as having a unique body of knowledge –medication 
expertise. All PCPs highly treasure the time and education provided by the MTM pharmacists, their ability to manage and adjust 
patients’ medications, and their capability to address patients’ medication experiences. MTM pharmacists are seen as being different 
from dispensing pharmacists, and PCPs usually highlight that difference to patients as they refer them to MTM services. Lastly, it is 
apparent that MTM pharmacists struggle to explain what their role is within the healthcare team and they need to find a more 




The face of healthcare is changing.  Governments along with 
individual health systems are changing the way they take care 
of patients in efforts to make health care more affordable 
and the health system sustainable.  Entire organizations are 
shifting to a team-based approach to health care, which 
requires collaboration between all health care providers to 
provide the best, most efficient and most cost-effective 
services to patients.  The role of each health care provider is 
being reexamined and redefined, so that patients can be seen 
in the timeliest manner and by the most qualified provider.
1,2
  
In the world of pharmacy, this shift can be seen with the 
preparation of pharmaceutical care practitioners, or 
medication therapy management pharmacists, that are 
capable of working collaboratively with other members of the  
health care team to ensure that patients are getting the best 




Despite the availability of effective medications in the 
market, the problems associated with the use – misuse, 
underuse, and overuse- of medications are overwhelmingly 
present and well documented in the literature.
7 - 12
  For 
patients with multiple chronic conditions the problem of 
inappropriate drug use is even more complicated as they 
usually see multiple providers, have complex medication 
regimens and are expected to fit the use of numerous 
medications into their daily lives.  Thus, utilizing the efforts 
and resources of all members of the health care team will be 
needed to build a medication use system that can help 
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patients achieve desired treatment goals and to resolve drug 
therapy problems hindering progress toward goals.
1,2,10, 13,14
 
Medication Therapy Management (MTM) services can 
provide the structure for a rational medication use process in 
that a team-based care, that includes the MTM pharmacist, is 
delivered to guarantee that all of a patient’s goals of therapy 
are met.
3,10
 Comprehensive medication management is a 
patient-centered service based on the philosophy and 
process of pharmaceutical care practice. It is defined as the 
standard of care that ensures each patient’s medications, 
including prescription, nonprescription, and supplements, are 
individually assessed to determine that each medication is 
appropriate for the patient, effective for the medical 
condition, safe given the co-morbidities and other 
medications being taken, and able to be taken by the patient 
as intended.  Comprehensive medication management 
includes an individualized care plan that achieves the 
intended goals of therapy with appropriate follow-up to 




Several studies have suggested that collaboration and 
coordinated care between pharmacists and physicians can 
enhance patient care outcomes.
16 - 24
 On the other hand, 
other studies have indicated that physicians looked at 
interprofessional collaboration as potential disruption of 
finances, patient-physician relationships and work 
satisfaction. Also, teamwork can be viewed by physicians and 





Many studies have investigated physicians’ perceptions and 
attitudes towards different aspects of pharmacy practice and 
pharmacist clinical roles.
21-24, 27,28
  Our study explored the 
experiences of primary care providers with MTM services 
when they have been working closely with a pharmacist in 
ambulatory clinics for several years. The context of this study 
is a large health delivery system that has implemented 
standardized pharmaceutical care-based medication therapy 
management services in Minnesota in 1998. Ramalho de 
Oliveira, Brummel and Miller presented a detailed description 
and the main outcomes of a decade of delivery of MTM 
services to almost 10,000 patients at this system.
10
  The 
pharmacists at this MTM program work at a full time basis in 
ambulatory clinics and are not associated with any dispensing 
activities. One of the core components of pharmaceutical 
care practice is collaboration with other members of a 
patient’s care team, and to date, no studies have been 
carried out to uncover the experiences of other health care 
providers with comprehensive MTM services in an 





Fairview Health Services, in partnership with the University of 
Minnesota, consists of 7 hospitals and 48 primary care clinics 
throughout the state of Minnesota.  Fairview Pharmacy 
Services, a subsidiary of Fairview Health Services, started 
developing MTM sites in 1998.  Fairview Pharmacy Services 
currently has 23 pharmacists providing MTM services in 26 
ambulatory care clinics.  All of the MTM pharmacists at 
Fairview Pharmacy Services practice under the philosophy 
and patient care process of pharmaceutical care.
3,6,10
  All 
MTM pharmacists have a pharmaceutical care certificate 
from the Peters Institute of Pharmaceutical Care at the 
University of Minnesota and are credentialed by Fairview 
Pharmacy Services.   
 
Fairview MTM pharmacists follow a standardized practice 
model, which ensures the consistent delivery of care to each 
individual patient. They provide an assessment, a care plan 
and a follow-up evaluation to each patient in order to prevent 
and resolve drug related problems and to make sure the 
goals of therapy are being achieved. Fairview MTM 
pharmacists work collaboratively in the clinic setting with all 
members of the team including providers (medical doctors, 
physician assistants and nurse practitioners), nurses, diabetes 
educators, behavior health clinicians and care coordinators. 
Some examples of patients that are referred to MTM services 
by any clinic staff member are: patients who are not reaching 
their therapeutic goals, patients taking multiple medications, 
patients who have questions about their medications, or 
patients who are not adherent to their medications. 
 
Fairview MTM pharmacists practice under a collaborative 
practice agreement that allows them to initiate, modify, or 
discontinue drug therapy and order laboratory tests for 
multiple medication classes used to treat many complex and 
chronic medical conditions. They also participate in clinic 
conferences, when patients’ cases are discussed and 
decisions are made between different members of the health 
care team. MTM pharmacists deliver care to patients in the 
clinic’s consultation rooms, as any other member of the 
team, and document their work/decision making in the 
electronic medical record (EPIC
®





Data collection and analysis 
For this qualitative study, semi-structured interviews were 
conducted with six (6) primary care providers (PCP’s) who 
were experienced and utilized MTM services in their 
practices.  The interviews were conducted from February 
through April of 2010. PCPs, including Medical Doctors 
(MD’s), Physician Assistants (PA’s), and Nurse Practitioners 
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(NP’s), working at one of Fairview Health Services’ clinics and 
with a minimum of 3 years of experience working with a 
MTM pharmacist were invited to participate in this study. If a 
PCP expressed interest, the researchers would contact the 
PCP to set up face to face interviews.  PCPs were assured of 
confidentiality; any information given could not be traced to 
individual subjects.  This study was approved by the 
Institutional Review Board at the University of Minnesota. 
Interviews lasted sixty minutes on average.  An interview 
guide was devised that listed open-ended questions focusing 
on providers’ experiences, reactions, beliefs, behaviors, and 
expectations related to MTM services. Moreover, the role 
and value of MTM services in providers’ practices were 
unearthed. Interviews were carried out in the providers’ 
clinics by the first author.  All interviews were audio-
recorded, with permission, and then transcribed verbatim.  
Transcripts were read multiple times by the three authors for 
an understanding of the whole and coded into emerging 
themes. The final themes were identified, discussed and 
agreed upon. Participant statements referring to each 
particular theme were grouped, further explored, and 
compared with initial key ideas.  Interpretations were 
discussed among all study investigators.   
 
Hermeneutic phenomenology as described by Max van 
Manen inspired the qualitative approach applied in this 
study.
29
   The goal of this research was to understand a 
human phenomenon and provider’s experiences of this 
phenomenon (MTM services within primary care practices). 
Hermeneutic phenomenology is a research methodology 
aimed at producing rich textual descriptions of the 
experiencing of selected phenomena in the lifeworld of 
individuals that are able to connect with the experience of all 
of us collectively.
30
  From identification of the experience of 
phenomena, a deeper understanding of the meaning of that 
experience is sought. This occurs through increasingly deeper 
and layered reflection by the use of rich descriptive language. 
 
Results 
A total of six PCPs were interviewed.  The participants 
consisted of four medical doctors and two physician 
assistants.  Three respondents were male and three were 
female.  PCPs had an average of seven years of experience 
working with MTM pharmacists, ranging from three to twelve 
years of experience. 
 
Six themes were identified upon analysis of the transcripts: 
(1) “MTM is just part of our team approach to the practice of 
medicine”: MTM as an integral part of PCPs’ practices; (2) 
“Frankly it’s education for the patient but it’s also education 
for me”: MTM services as a source of education; (3)  “It’s not 
exactly just the pharmacist that passes out the medicines at 
the pharmacy”: The MTM practitioner is different from the 
dispensing pharmacist; (4) “So, less reactive, cleaning up the 
mess, and more proactive and catching things before they 
become so involved”: MTM services as preventative health 
care efforts; (5)“I think that time is the big thing”: MTM 
pharmacists spend more time with patients;  (6) “There’s an 
access piece, there’s an availability piece, there’s a finance 
piece”: MTM services are underutilized at the clinics. 
 
1. “MTM is just part of our team approach to the 
practice of medicine”: MTM as an integral part of 
PCPs’ practices 
For the participants in this study, MTM services became an 
important component of their clinical practices. PCPs 
understood that the integration of MTM into the process of 
caring for their patients is part of the evolution of medicine, 
as it was clearly articulated by the following participant: 
 
You’d almost have to be living in a cave these days not to 
be affiliated with MTM, or to be open to it.  I know 
there’s probably plenty of people who are a little 
resistant to new ideas and new people, and feeling like 
this is my job to write these prescriptions and change 
them as I see fit.  But there’s just a lot of bad medicine 
being practiced frankly, and newer isn’t greater, it’s not 
safer, necessarily…MTM is just part of our team approach 
to the practice of medicine. 
 
Participants considered the inclusion of MTM into the care 
team is an innovation in the practice of medicine, which, as 
any change, might cause some resistance in the beginning. 
Over time, PCPs learned how to utilize MTM services in their 
practices and it became a part of their day-to-day lives at the 
clinics. PCPs described MTM pharmacists as “another set of 
eyes to look at patients’ needs and provide unique solutions 
to problems”. The collaboration between the participants 
PCPs and MTM pharmacists was experienced through direct 
and transparent communication. MTM pharmacists 
communicate all their decisions and recommendations via 
the electronic medical record so that the other providers feel 
informed and involved in the care process, as stated by the 
following participant:  
 
I know that my MTM is always going to let me know 
what’s going on, they always forward changes so they let 
me know what they’ve done…I know this is a very 
collaborative relationship, so I don’t have to be concerned 
that there are going to be things happening with my 
patients and changes made that I’m going to freak out 
about later. 
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MTM pharmacists persistently are in contact with providers 
sharing information through the electronic medical record, 
which gives providers peace of mind. Development of trust 
through open communication and willingness to collaborate 
create an environment in which PCPs can ensure their 
patients are receiving the best possible care.  In this study, 
providers emphasized the confidence they have in the 
knowledge and competence of MTM pharmacists. They are 
also open to working together with the MTM pharmacist “to 
make changes and adjustments to meet our goals that we’re 
trying to reach together”.  This means that providers and 
MTM pharmacists are ‘on the same page’, or they share the 
same goals for their patients. This seems to be a extremely 
important prerequisite for teamwork.  
 
As it was mentioned before and should be emphasized once 
more, within Fairview Health Services, MTM pharmacists 
work under a collaborative practice agreement that allows 
them to initiate, modify and discontinue medications for 
many different medical conditions. The participants in this 
study appreciated the fact that pharmacists have that level of 
autonomy and found that to be very helpful to their practices 
and their capacity to resolve patients’ health problems. 
PCPs commented on the fact that MTM pharmacists are 
physically present at the clinic, which facilitates 
communication and relationship building.  MTM pharmacists 
became part of their practices as they provide a service that 
augments their own patient care practices, as it is illustrated 
in the following passage: 
 
I have a really busy practice, I have a lot of patients with 
a lot of medical problems, and I don’t have near enough 
time to spend, the time that the patient needs in all the 
education.  And again, a lot of patients are on a lot of 
medications, so I really feel like it’s a huge augmentation 
to my practice to have MTM close by.  The close by is a 
big piece of it too I think; the fact that MTM is right here 
in our clinics several days a week and also available 
through our medical records system. I can contact them 
any time and we’ve worked together enough and trust 
each other enough that you can talk to them anytime 
about questions about medications, questions about 
patients, so I feel like it has become an integral part of 
my practice. 
 
Oftentimes there may be hesitancy on the part of the MTM 
pharmacist, for fear that providers may feel the pharmacist is 
impinging on their practices, or that providers are not open 
to pharmaceutical care or do not wish to collaborate.  The 
PCPs interviewed in this study did not express this attitude by 
any means.  On the contrary, PCPs seemed aware of this fear, 
but welcomed collaboration with the MTM pharmacist.  
 
I’ve never felt uncomfortable with the situation.  I think 
there are some practitioners who always feel a little 
threatened…they feel like somebody’s usurping their 
powers to make changes for their patients or to be the 
one who manages their patients, and I’m just not that 
type of provider.  I welcome recommendations and 
teamwork and that kind of thing.  I think there’s a lot of 
value there. 
 
The narratives of PCPs emphasized the importance of 
developing trust between members of the health care team, 
the importance of clear communication, the willingness to 
collaborate and leveraging the strengths of individual team 
members to best care for patients. 
 
2. “Frankly it’s education for the patient but it’s also 
education for me”: MTM services as a source of 
education  
As MTM pharmacists further define their role and 
responsibilities on the health care team, PCPs underscored 
over and over again how important it is that MTM 
pharmacists provide education about medications.  PCPs 
highly valued when MTM pharmacists educate patients 
regarding their medication regimens: 
 
I use MTM when I feel like the patient needs more 
education on a medication.  When I feel like we can 
improve their adherence to and success with a 
medication by making sure they’re taking it 
appropriately, making sure that they know what it’s for.  
It’s kind of that, the reason things work is patients need 
to think it’s going to work, the provider needs to think it’s 
going to work, it actually has to work, and they have to 
take it.  So, if one of those is out of place, it’s not going to 
be a successful treatment.  And having MTM to sort of be 
that champion for some of these treatments I think is 
very helpful. 
 
Providers expected that the MTM pharmacist would dedicate 
a good amount of time educating patients about their 
medications. Moreover, an unexpected finding was that 
providers also depended on the MTM pharmacist for their 
own education, as this next quote indicates:   
 
There’s two things: one, I hope that the patient can learn 
something…but also I think that I end up learning 
something because I read her notes, and her comments 
to me, and it’s like, “oh that’s a great idea, take this 
medication at night, or let’s do this, or split this pill in 
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half, or don’t take it with this one”, so frankly its 
education for the patient but it’s also education for me. 
 
Providers also relied upon their MTM pharmacist to bring a 
different perspective to a challenging patient case, for 
instance, when they feel a patient may need some additional 
help, or a different kind of help. 
 
If the patient is seeing *the MTM+, my philosophy is I’ve 
exhausted everything I can do, now its your turn to kind 
of look at things, and feel free to do whatever you need 
to do to sort of find better care.  I mean, we’re all trying 
to do the same thing. 
 
Thus, PCPs relied on the MTM pharmacist’s expertise in 
medications to provide in depth education to patients on 
their drug therapies.  Additionally, PCPs cherished having the 
MTM pharmacist available to answer their own questions 
about new drugs, proper doses of medications, and safe 
prescribing.  PCPs also depended on the MTM pharmacist to 
provide a second opinion on treatment options for patients. 
 
3. “It’s not exactly just the pharmacist that passes out 
the medicines at the pharmacy”: The MTM 
practitioner is different from the dispensing 
pharmacist 
When providers were asked how they describe MTM services 
or the role of the MTM pharmacists to others, a wide variety 
of responses were provided. They acknowledged that the 
focus of medication therapy management services is the 
patient and not a drug product.  Interestingly, they usually 
described the service in terms of their knowledge of what a 
pharmacist traditionally does, compared to their experiences 
working with a MTM pharmacist.   
 
I see you as a provider; I see your role as a medical 
provider on the team, which is sort of different than the 
druggist role that people sort of assume pharmacists take 
on.   
 
Even when they referred a patient to MTM services, PCPs 
strived to differentiate the MTM pharmacist from the 
dispensing or more traditional pharmacist: 
 
How do I explain [MTM to my patients]?  I usually say 
they are a pharmacist with a doctorate, so I’d say “it’s 
not exactly just the pharmacist that passes out the 
medicines at the pharmacy, but this is a person with a lot 
more knowledge about the specific diseases and how to 
treat them, we work together to help you manage this 
condition better. 
Some providers had a difficult time explaining what the 
service was, as it is shown below: 
 
I think it’s hard to really explain it.  It’s like you really 
have to work with it and see how it can benefit everyone.  
Once you’re actually working with that person *the MTM 
pharmacist+ you really get a sense of that.  So it’s hard to 
just tell someone…I wonder how you would explain, if 
someone asked “what do you do?” How do you say it in a 
succinct, short…because for me, I could go on and on and 
on. 
 
Perhaps because medication therapy management services 
are somewhat new to health care, or because most providers 
themselves had never experienced an MTM encounter, it was 
difficult for some providers to describe exactly what MTM 
was, or to have a clear way to explain the service to others.  
One provider asked the interviewer how she describes the 
service.  Another provider mentioned it would be nice for the 
MTM pharmacist to provide scripting of how to describe 
MTM to patients, so the physician would have a convincing 
way to encourage patients to meet with the MTM 
pharmacist. 
 
Having that quick little scripting that you can give 
patients.  You want to have that quick little, “ok I’d like 
you to see our MTM pharmacist, this is what they do…”.  
And then, just to know kind of what to say, exactly how 
to explain what they do, without sounding like your 
rambling on and on. 
 
It does not appear that years of experience working with 
MTM services correlated with better or worse descriptions of 
medication therapy management.  PCPs with as little as three 
years of experience working with MTM had no problems 
explaining what they thought MTM was and what type of 
work the MTM pharmacist does with patients.  On the other 
hand, there were PCPs with up to twelve years of experience 
working with a MTM pharmacist who still had a difficult time 
describing MTM services to patients, and to the interviewer.  
Despite how a PCP described MTM services, every PCP made 
a disctinction between “the pharmacist behind the counter” 
and the MTM pharmacist. 
 
4.  “So, less reactive, cleaning up the mess, and more 
proactive and catching things before they become 
so involved”: MTM services as preventative health 
care efforts 
One area that all providers seemed to agree upon was that 
MTM pharmacists are able to focus on many aspects of 
patient safety.  Providers felt that a benefit of MTM services 
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was that the MTM pharmacist helped manage complex 
patients on many medications, and helped prevent or find a 
solution to a drug related problem a patient may be 
experiencing.  Repeatedly, providers expressed that when 
they “have a patient that has a lot of medications, is having 
some side effects, is having difficulty finding appropriate 
medications or tolerable medications to manage their 
problems…that those are good patients to send to MTM to do 
that review and to use them and their knowledge” to help 
manage patients better.   
 
Participants’ narratives suggested that providers utilized 
MTM pharmacist as a safety net for safe-prescribing practices 
that would in turn provide safety for the patient: 
 
I think that is just patient safety is at stake.  I mean, I 
really believe that.  Because it just, docs are just, we just 
punt, we guess, we think we know.  We don’t really 
know.  Maybe they *pharmacists+ don’t either, because I 
know it’s as much art as anything, but they’ve got the 
system in place to make it work so things don’t slip 
through the cracks. 
 
In this case, the provider was referring to the rational 
decision-making process of pharmaceutical care, in which the 
MTM pharmacist assesses the indication, the effectiveness, 
the safety, and the convenience of a patient’s drug therapy.  
Even though PCPs cannot articulate well the kind of rational 
decision making pharmacists use, they know that they utilize 
a patient care process that is logical, consistent and 
reproducible. Furthermore, the provider indicated that he 
depends on the pharmacist’s expertise in pharmacotherapy 
to catch errors that may be made during prescribing.  Again, 
the theme of collaboration is intertwined with providing safe 
and efficient care for the patient, as the following quote 
illustrates: 
 
The role of the MTM is to make recommendations in 
terms of, if patients are having problems with 
medications or if there are more efficient or effective 
ways to manage whatever issue they’re discussing.  I 
know it varies because sometimes it’s specific to 
something like diabetes or asthma, and sometimes it’s 
much more generalized when we say, “ok can you see my 
patient and they have 15 medications and they’re having 
some problems, can you help look at that?”  Again, 
collaborative to help us figure out, “ok, they’re having 
problems, is it related to medications?  Do you think 
there’s a change we could make here to create less 
problems for this patient, decrease the amount of side 
effects?”  Collaborative helping with particular problems 
and then in general when we just say “just take a look 
here and see what you think about this patient’s 
situation.” 
 
Undoubtedly, MTM pharmacists are depended upon to help 
implement and oversee safety in the care of complex patients 
on multiple medications.  However, as the role of the MTM 
pharmacist expands and grows, some PCPs are learning to 
utilize MTM services as a proactive measure to ensure patient 
safety, rather as a reactive measure. 
 
I think that rather than being a reactive thing…rather 
than sorting through the mess or helping us wade 
through that, we’re now much more proactive.  There is 
just, if pharmacokinetics is at work, and its diabetic care, 
or hypertensive care, or the use of a substance like 
nicotine, I really see the pharmacist having very unique, 
special, good knowledge along those lines.  So, less 
reactive, cleaning up the mess, and more proactive and 
catching things before they become so involved. 
 
According to the PCPs participating in this study, MTM 
pharmacists are contributing to preventative health efforts as 
they care for patients with several chronic conditions to 
ensure they are on appropriate medication regimens, finding 
ways to optimize their medications and meet goals of therapy 
before they become the stereotypical “train-wreck” patient 
on 15 or more medications.   
 
5. “I think that time is the big thing”:  MTM 
pharmacists spend more time with patients 
Likely the most common theme identified in this study, the 
time MTM pharmacists are able to spend with patients was 
one of the most valued aspects of the service. PCPs 
repeatedly underscored the fact that MTM pharmacists can 
spend more time with patients than most providers.  Within 
the Fairview system, MTM pharmacists meet with new 
patients for 60 minutes and follow-up patients for 30 
minutes. Within that time, the MTM pharmacist ensures that 
the patient understands the reasons he or she is on each of 
their medications, educates the patient on how the 
medications work and strives to increase the patient’s 
understanding of the importance of taking their medications 
properly.  Providers openly emphasized their lack of time and 
focus on educating patients about their medications. 
Overtime PCPs learned to utilize MTM pharmacists for drug 
education and started depending on them for that, as the 
following passage exemplifies: 
 
It feels like MTM sometimes has more time with 
patients, because we’re sort of forced into the 
stereotypical mold of “see as many patients fast as you 
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can”.  It’s really nice for me to see a patient, newly 
diabetic, newly asthmatic, COPD…take your pick of other 
conditions that we could add to that and say, “you 
know, I really want you to see our MTM and take some 
time with them, and they can kind of just go through, 
here’s what your meds are for, here’s the side effects, 
here’s what’s gonna happen”.  Because, usually what 
happens is, I get in there, and we talk about the 
diabetes, and I say, here’s your metformin, have a good 
day, and only have 2 minutes to explain to them what 
it’s for and why it works and what it’s doing inside the 
body. 
 
Many times, when PCPs meet with their patients, it is to 
address an acute need the patient has that day.  It is common 
for chronic conditions to go unaddressed if it is not the source 
of an acute concern.  Because the MTM pharmacist has more 
time to spend with the patient, providers believe that the 
pharmacist and the patient can focus the visit on the chronic 
medications and chronic conditions, ensuring that the patient 
is still working towards, if not achieving their goals of chronic 
therapy.  When goals of therapy are not being met, the MTM 
pharmacist and the patient have time to make the proper 
changes to a patient’s medication regimen, depending on 
what the patient’s barriers to achieving goals of therapy are. 
As it is shown in the next quotation, PCPs recognized that 
MTM pharmacists use their time not only for educating 
patients about their medications but also for engaging in 
medication management: 
 
I think that time is the big thing.  The amount of time he’s 
able to spend with patients.  I mean, it’s really hard to 
adequately manage a diabetic in 15 minutes.  And the 
fact that he can manage the medication part too.  So he 
can do the education, but he can also adjust medications, 
or change things, and just really get into the details. 
 
According to the participants in this research, another way 
that MTM pharmacists use their time with patients is to 
address any behavioral or experiential issue that might be 
getting in the way of them getting the benefit of the drug 
therapy. 
 
I try to use what I can to help them [patients] to 
understand what I’m recommending to them.  So if 
they’re fearful about something or if they’re having a 
problem then I say, “Hey, let’s use this resource *MTM+. 
This a knowledgeable person who can help us out and 
spend a lot of time with you, help you to understand this 
better.” 
 
Therefore, from the perspectives of the interviewed 
providers, MTM pharmacists have more time with patients 
and they use this time to educate them about medications, to 
manage/adjust medications and to address patients’ 
experiences and behaviors regarding medications. 
 
6. “There’s an access piece, there’s an availability 
piece, there’s a finance piece”: MTM services are 
underutilized at the clinics 
The Medication Therapy Management Department within 
Fairview Health Services provides services to Medicaid 
beneficiaries taking 4 or more prescriptions to treat or 
prevent 2 or more chronic medical conditions, patients 
enrolled with contracted Medicare Part D plan sponsors, 
beneficiaries of contracted self-funded employers, all 
Fairview employees regardless of the number of diseases or 
medications, and private-pay patients.  This means that at the 
time this research was conducted there were many patients 
seen at Fairview clinics that were not eligible for MTM 
services.  Additionally, the majority of the MTM pharmacists 
split their time between two clinics, thus being only at one 
clinic for two or three days out of a week.  In general, the 
MTM pharmacist is not available to one clinic exclusively and 
is not available to all patients. However, PCPs believed that 
most patients that are on medications would benefit from 
MTM services and they would use them much more often if it 
was a covered service:  
 
Every single visit I see there’s a prompt.  The only time I 
wouldn’t use a MTM person, would be someone who’s 
not on any medications!  So if virtually half our patients 
or more could utilize a MTM provider, why don’t we do it 
more?  I think part of it is expense.  If it’s not covered by 
insurance… *our MTM+ can’t do it out of the goodness of 
her heart.  And frankly, right now, it’s limited availability.  
Our patients are at our clinic now; most of them don’t 
want to go back to the primary care center.  They will if 
they have to, but that’s not convenient anymore because 
they’re so used to this easy access that we have.  So 
there’s an access piece, there’s an availability piece, 
there’s a finance piece. 
 
It can be inferred that if the MTM practitioner had more of a 
presence in the clinic, and the services were either covered 
by all health plans or were available to any patient, MTM 
services would be utilized more.   
 
From an insurance standpoint, I would utilize them a lot 
more if it was covered.  Like practically for any patient 
that was on more than a few medications I probably 
would involve them.  Or any chronic health conditions 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                           2012, Vol. 3, No. 1, Article 72                       INNOVATIONS in pharmacy   8 
 
where they may be able to help optimize which 
medications they *patients+ are taking.  I think it’s a little 
limited, I wish I could use [MTM] a lot more, I really do.  I 
just think that it’s so limited because the patients don’t 
even want to pay to come see me in three months for 
their diabetes, let alone see me and…healthcare is so 
tight. 
 
Although the lack of availability of the MTM pharmacist at the 
clinic at a full-time basis limited the access of patients to the 
service, cost appeared to be the main reason for both 
underutilization of MTM services and frustration on the part 
of PCPs: 
 
I love having [our MTM] here.  I think it adds a lot of 
value.  I mean it’s extremely helpful.  The drawback is 
that people have to pay for it.  And not many insurance 
plans cover it. It’s like to have that resource and not be 
able to use it to the full advantage, because of the barrier 
of payment, is frustrating because it’s so valuable. 
 
PCPs also mentioned that transportation could be an issue for 
patients who need to come back to clinic on a day when the 
MTM pharmacist is there.  Several providers referred to the 
use of “telemedicine”, or seeing patients via the intranet as a 
solution. 
 
I know that there is already work on sort of almost that 
telemedicine type thing, where we’re doing sort of video 
conferencing with patients and that helps in terms of 
those “I can’t get to the clinic again” kind of thing. 
 
On the whole, it seemed that providers would utilize MTM 
services more if the MTM pharmacist was in clinic more often 
and if the services did not have to be paid out of pocket by 
the patient. The fact that some patients’ insurance will 
reimburse for the service, and others will not, is a source of 
frustration to PCPs as they believed most patients who take 
medication would likely benefit from the service. They also 
acknowledged that it is difficult for patients to pay out of 
pocket for MTM services when it is hard for them to pay for 
medical services. Finally, PCPs recognized telemedicine or 
virtual MTM as a potential way to circumvent the problem of 
accessibility of MTM pharmacists in the clinics. 
 
Discussion 
In this study, primary care providers shared their experiences 
with and perspectives on MTM services that had been 
available to their patients and clinics over the last several 
years. The experiences and points of view were mostly 
positive.  The participant PCPs emphasized how they value 
having an MTM pharmacist in their clinics and that MTM 
services had become an integral part of their practices. The 
physical presence of MTM pharmacists at the clinic and their 
ability to communicate about patients via the electronic 
medical record create the right environment for relationship 
building between PCPs and MTM pharmacists. 
 
Providers stated that one of the things they treasure the most 
is the education that patients and themselves gain from MTM 
pharmacists. MTM pharmacists have a different type of 
expertise - knowledge about medications- that add to the 
knowledge of primary care providers. Another study 
conducted in an inpatient medical setting has also found that 
physicians and nurse practitioners felt that the addition of 
pharmacists on the team had a positive impact on overall 





Because collaboration and trust between PCPs and MTM 
pharmacists had developed over the years in the study 
setting, providers appreciated the fact that MTM pharmacists 
are able to not only educate patients but also to adjust their 
medications. MTM is a value-added service to the practice of 
PCPs in that MTM pharmacists provide education, assist 
physicians in managing patients’ drug therapy and attend to 
patients’ unique experiences and behaviors regarding their 
use of medications. Providers believed that one way that 
MTM pharmacists are helpful to them is due to the fact that 
collaborative practice agreements are in place within 
Fairview, allowing these pharmacists to initiate, modify or 
discontinue drug therapy for numerous medical conditions. 
The significance of collaborative practice agreements (CPAs) 
in this setting cannot be underestimated as they allowed 
MTM pharmacists to add more substantial value to the team. 
It is apparent that the implementation and subsequent 
expansion of these CPAs in this health delivery system 
strengthened the position of MTM services within the health 
care team. Thus, the authors would like to point out the 
importance of legislation that supports the execution of these 
agreements as the one in the State of Minnesota. 
 
Interestingly, besides acknowledging that MTM pharmacists 
use their time with patients to provide education and adjust 
medications, PCPs also recognized the significance of having 
pharmacists to address patients’ behaviors regarding 
medication taking. We understand that when PCPs referred 
to the behavioral aspects of taking medications, they were 
pointing out the ability of the MTM pharmacist to attend to 
and improve the patient’s medication experience. Several 
studies have indicated that addressing the patients’ feelings, 
understandings, concerns and behaviors around medications 
– the patient’s medication experience– is one of the most 
important aspects of the practice of pharmaceutical care and 
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medication management services as these subjective 
experiences might be at the root cause of drug therapy 
problems.
31, 32, 33
  Thus, it is interesting to notice that PCPs 
acknowledged the positive influence MTM pharmacists can 
have in the behavioral aspects associated with drug therapy. 
 
Furthermore, from providers’ perspectives, MTM services 
should be utilized as preventative measures in patients with 
multiple chronic conditions to guarantee that patients are 
receiving the most benefit from their pharmacological 
treatments. They understand that pharmacists offer a safety 




As healthcare changes to focusing more on delivering greater 
value, non-physician health care providers are starting to play 
a more significant role in the delivery of patient-centered 
services.
1,2.5,11,12
  In shifting to a team-based approach to care, 
inter-professional collaboration becomes essential to 
improve quality and efficiency. The inclusion of 
comprehensive medication management services in patient-
centered medical/health homes is advocated by the Patient-
Centered  Primary Care Collaborative, a coalition of major 
employers, consumer groups, patient quality organizations, 
health plans, labor unions, hospitals, and clinicians who have 
joined together to develop and advance the patient centered 
medical home:  
 
“For patients on multiple or chronic medications, 
pharmacists, who are trained to provide comprehensive 
medication management services, have the necessary 
expertise to help them and their health care team in the 
PCMH [patient-centered medical home] to maximize the 





Another study, conducted in Pennsylvania, carried out focus 
groups with 23 physicians in order to understand the 
perceived benefits and concerns related to MTM provided by 
community dispensing pharmacists.
28
  This study found that 
overall physicians had a negative perception of community 
pharmacist-provided MTM.  Physicians felt that they were 
better suited to provide MTM services and were concerned 
with the preparation of the pharmacist and the lack of 
relationship between the PCP and the MTM pharmacist.
28
  
These two studies differ significantly.  In the Pennsylvania 
study, many of the physicians were not familiar with MTM 
services, and only four of the twenty-three physicians worked 
side by side with a pharmacist to optimize patient care.  In 
this study, each PCP had worked closely with a MTM 
pharmacist for a minimum of three years.  Additionally, in 
most cases, PCPs in our study shared a common space, or 
“provider office” in the clinic with the MTM pharmacist.  
Another point of interest in the Pennsylvania study is the 
finding that physicians were concerned with the 
training/preparation of the pharmacist and the need for “an 
established, trusting relationship” between the pharmacist 
and physician.  In our study, this relationship was already 
established, and one could argue that this is a result of the 
close proximity and the length of time in which pharmacists 
and providers have worked together at the clinics. A 
previously developed theoretical framework for 
physician/pharmacist collaboration working relationships 
posits that the more the providers communicate with each 
other and the more physicians utilize pharmacists’ services, 
the greater the collaboration between them.
34
  We also 
believe that the clinic setting in which Fairview MTM 
pharmacists practice represents a major asset that allows for 
open communication and development of trusting 
relationships with PCPs. Other studies also indicate that 
proximity is an essential component for collaboration 




Another important issue that emerged in this study was that 
PCPs wanted some guidance on how to explain MTM services 
to others.  PCPs at times asked for scripting on how to 
describe the service or suggested that spending time with the 
MTM pharmacist may better increase their understanding of 
medication therapy management.  Pharmacists, who work in 
collaboration with providers, may benefit by engaging in 
discussion of their role in patient care and be able to answer 
questions clearly about medication therapy management 
services.  Other PCPs reported having a very clear 
understanding of MTM and often explained the service to 
patients by differentiating MTM pharmacists from “the 
pharmacist behind the counter”.  Another research that 
conducted focus groups with patients also indicated, in this 
case from patients’ perspectives, that physicians have a hard 
time to explain to patients what MTM services are and how 
they can help patients.
35    
Therefore, MTM pharmacists must 
make every effort to better describe what their roles are and 
what kind of value they are able to add to the health care 
team. 
 
The MTM pharmacist was described as having “more 
knowledge” or a higher educational degree than a dispensing 
pharmacist – which is arguably untrue.  Although the day to 
day functions and focus of a MTM pharmacist may differ from 
those pharmacists working in a community pharmacy, the 
education and training is generally the same.  This then begs 
the question: do providers have an understanding of the 
training and qualifications of a pharmacist?  Based on the 
American Medical Association Scope of Practice of a 
Pharmacist, released in September of 2009, the answer is 
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  The AMA states that “while pharmacists’ knowledge of 
drugs may be strong, their ability to collect and assess 
subjective and objective clinical patient information as a 
means to initiate drug therapy or to monitor therapeutic 
progress is neither taught nor emphasized in pharmacy 
school.”
36
  However, the PCPs interviewed in this study and 
the many studies before mentioned in this paper suggest 
otherwise.  This is likely a question to be addressed in future 
qualitative studies.  
 
The six themes that emerged from this research can be 
contextualized in today’s changing healthcare environment.  
The United States government is searching for ways to make 
healthcare more affordable and make the health system 
sustainable.  Within Fairview Health Services specifically, 
changes are being made to transform the health delivery 
system into an Accountable Care Organization (ACO).  The 
goal of Accountable Care Organizations is to reduce, or at 
least control the growth of, healthcare costs while 
maintaining or improving the quality of care patients receive 
(in terms of both clinical quality and patient experience and 
satisfaction).
37
  In this context, pressure has been placed into 
the hands of primary care clinics to find ways to be more 
efficient and more effective so that more value can be 
achieved.  Based on the responses from PCPs, MTM services 
have been an integral part of bridging the gap between the 
old and the new approach to patient care.  Interestingly, a 
recent perspective article discussed factors for why patients 
were not receiving optimal care.
38
 This editorial suggested 
that patient adherence and health outcomes could be 
improved by focusing on optimizing and reconciling 
medications, coordinating care and sharing electronic data, 
and engaging and supporting patients on an individual level.  
The article goes on to say that there is currently no model 
available to do this.  It is these authors’ belief that MTM 
services can help to bridge this important gap existing in 
today’s healthcare.  Through patient and provider education 
as well as comprehensive medication management, 
pharmaceutical care-based MTM services can add significant 
value to primary care practices which might lead to improved 
clinical outcomes. 
 
Lastly, it should be stated that presently MTM pharmacists 
within Fairview Health Services are delivering MTM services 
to patients virtually, as suggested by some participants in this 
study. Hence, even when the MTM pharmacist is not able to 
be physically present at the clinic as the patient comes back 
for a follow-up visit, he or she can be virtually present to care 
for that patient. This initiative is noticeably increasing the 




MTM pharmacists who work closely with PCPs were 
responsible for referring the providers to the researchers.  
Due to the nature of the relationship between the MTM 
pharmacists and the PCPs, one could argue that the 
researchers only interviewed PCPs who had positive 
experiences with MTM services.  Another limitation of this 
study is that the primary researcher and interviewer was also 
a MTM pharmacist.  Despite efforts to elicit honest and 
unbiased perspectives, it is possible that providers were 




This study found that Comprehensive Medication Therapy 
Management services are treasured by primary care 
providers in the ambulatory setting.  Primary care providers, 
who utilize MTM services in their practices, considered the 
MTM pharmacist to be an integral member of the health care 
team.  Providers who have extended experience working with 
MTM pharmacists recognized that these professionals add 
significant value to the care of the patient not only by 
providing education about medications, but also by being 
able to manage and adjust medications as well as addressing 
behavioral challenges concerning medication taking. 
Furthermore, providers believed that instead of using MTM 
services as a reactive intervention in the care of very 
complicated patients, these services should be utilized as 
preventative measures in patients with multiple chronic 
conditions to guarantee that patients are receiving the most 
benefit from their pharmacological treatments. On the other 
hand, it is difficult and frustrating for providers when MTM 
pharmacists are not available at their clinics at a full-time 
basis and MTM services are not consistently covered by most 
health plans. Finally, it is apparent that MTM pharmacists 
struggle to explain what their role is within the healthcare 
team and they need to find a more effective way to explain 
the unique value they add to the care of patients.  
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